Mark A. Gillman
Mark A. Gillman (BDS, M.S., and D.S. degrees) was born in Johannesburg, South Africa and continues to live there. He is currently the CEO of the S.A. Brain Research Institute and has held professorships and senior appointments at both local and overseas universities. His main interest is the actions of psychotropic analgesic nitrous oxide (PAN) on the human brain. PAN is low, nonanaesthetic concentrations of nitrous oxide mixed with high concentrations of oxygen, as used in dentistry. Using PAN, he and colleagues discovered the new principle of biology (Gaseous, neurotransmission) between 1980 and 1983, which was confirmed almost 10 years later by workers at Johns Hopkins Medical School. Gillman and colleagues also uncovered endorphin links to human sexual response, anorexia nervosa, and Tourette syndrome. In addition, they discovered a treatment for substance abuse with PAN, which has been used successfully in South Africa, Finland, and the USA in thousands of cases. He has lectured on PAN over 250 times to lay and scientific audiences locally and internationally, having 290 publications plus 4 full-length books, a best-selling CD on the technique of conscious sedation with PAN, and many international editorial appointments. He has acted as a Reviewer for numerous journals, including the Lancet and BMJ.
Biography Updated on 15 March 2011